14 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34455758 | Effects of Telmisartan, an AT1 receptor antagonist, on mitochondria-specific genes expression in a mouse MPTP model of Parkinsonism. | 2021 Aug 30 | 4 |
2 | 34464088 | Telmisartan Mitigates High-Glucose-Induced Injury in Renal Glomerular Endothelial Cells (rGECs) and Albuminuria in Diabetes Mice. | 2021 Sep 20 | 1 |
3 | 32726122 | AT1/2R affects the proliferation and apoptosis of chondrocytes induced by oxygen-glucose deprivation. | 2020 | 3 |
4 | 31114640 | Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model. | 2019 Apr 27 | 1 |
5 | 30006683 | Telmisartan Ameliorates Astroglial and Dopaminergic Functions in a Mouse Model of Chronic Parkinsonism. | 2018 Oct | 1 |
6 | 27562117 | Type-1 angiotensin receptor signaling in central nervous system myeloid cells is pathogenic during fatal alphavirus encephalitis in mice. | 2016 Aug 25 | 1 |
7 | 24578472 | Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions. | 2014 May | 2 |
8 | 23747572 | Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. | 2013 Oct | 4 |
9 | 21156825 | Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase. | 2011 Apr 1 | 2 |
10 | 19136706 | Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan. | 2009 May | 1 |
11 | 19699780 | Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism. | 2009 Oct 30 | 1 |
12 | 16888236 | Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. | 2006 Oct | 2 |
13 | 15728568 | Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. | 2005 Mar | 2 |
14 | 16043867 | Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. | 2005 Aug | 1 |